You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor α antagonists: differential effects between good and poor clinical responders

Article info

Article menu
Download PDFPDF
Extended report
B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor α antagonists: differential effects between good and poor clinical responders

Authors

  1. W Stohl, Division of Rheumatology, University of Southern California, 2011 Zonal Ave. HMR 711, Los Angeles, California 90033, USA; stohl{at}usc.edu
View Full Text

Citation

La DT, Collins CE, Yang H, et al
B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor α antagonists: differential effects between good and poor clinical responders
Annals of the Rheumatic Diseases 2008;67:1132-1138.

Publication history

  • Accepted October 22, 2007
  • First published October 29, 2007.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism